Pharmaceutical composition for treating and preventing cardiovascular disease
OwnerYaguang Liuinventor
Life of this patent
Estimating the term…
Abstract
The new pharmaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease. The fine-PTC is composed of following ingredients: Puerarin or derivative of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysaccharides and Saponin of Dangshen. The composition is nontoxic.
Claims4
A crude pharmaceutical composition derived from plant extracted by ethanol, comprising a mixture of about 10-50% of Pueraria lobata (willd.) Ohwi, or Pueraria thomsanii Benth;
- 10-50% of Salvia miltiorrhiza Bunge, Salvia przewalskii Maxim or Salvia trijuga Diels;
- 10-50% of Ligusticum chuanxiong Hort or Ligusticum wallichii Franch;
- 10-50% of Codonopsis pilosula Nannf, Codonopsis tangshen Oliver or Codonopsis clematidea Clarke.
A pharmaceutical composition for treating cardiovascular disease comprising:
- a. puerarin or derivaties thereof 10-50 wt. %;
- b. danshensu or danshenketone, 10-50 wt. %;
- c. tetramethyl pyrazine 10-50 wt. %;
- d. polysaccharides of dangshen, 5-25 wt. %;
- and
- e. saponin of dangshen 5-25 wt. %.
A method for treating a human suffering from vascular disease comprising administering to said human an effective amount of a composition comprising:
- a. puerarin or derivaties thereof 10-50 wt. %;
- b. danshensu or daunshenketone, 10-50 wt. %;
- c. tetramethyl pyrazine 10-50 wt. %;
- d. polysaccharides of dangshen, 5-25 wt. %;
- and
- e. saponin of dangshen 5-25 wt. %.
Dependencies are inferred from the claim text.